Preparation, characterization, and in vivo evaluation of injectable long-acting curcumin microcrystal

References

• Aditya, N. P., H. Yang, S. Kim, and S. Ko. 2015. Fabrication of amorphous curcumin nanosuspensions using β-lactoglobulin to enhance solubility, stability, and bioavailability. Colloids & Surfaces B Biointerfaces 127:114–21. doi:10.1016/j.colsurfb.2015.01.027
   PubMed Web of Science ®Google Scholar
• Ahuja, B. K., S. K. Jena, S. K. Paidi, S. Bagri, and S. Suresh. 2015. Formulation, optimization and in vitro–in vivo evaluation of febuxostat nanosuspension. International Journal of Pharmaceutics 478 (2):540–52. doi:10.1016/j.ijpharm.2014.12.003
   PubMed Web of Science ®Google Scholar
• Baert, L., G. van‘t Klooster, W. Dries, M. François, A. Wouters, E. Basstanie, K. Iterbeke, F. Stappers, P. Stevens, L. Schueller, P. Van Remoortere, G. Kraus, P. Wigerinck, and J. Rosier. 2009. Development of a long-acting injectable formulation with nanoparticles of rilpivirine (TMC278) for HIV treatment. European Journal of Pharmaceutics and Biopharmaceutics 72 (3):502–08. doi:10.1016/j.ejpb.2009.03.006
   PubMed Web of Science ®Google Scholar
• Bhakay, A., M. Merwade, E. Bilgili, and R. N. Dave. 2011. Novel aspects of wet milling for the production of microsuspensions and nanosuspensions of poorly water-soluble drugs. Drug Development and Industrial Pharmacy 37 (8):963–76. doi:10.3109/03639045.2010.551775
   PubMed Web of Science ®Google Scholar
• Gao, Y., Z. Li, M. Sun, C. Guo, A. Yu, Y. Xi, J. Cui, H. Lou, G. Zhai. 2010. Preparation and characterization of intravenously injectable curcumin nanosuspension. Drug Delivery 18 (2):131–42. doi:10.3109/10717544.2010.520353
   PubMed Web of Science ®Google Scholar
• Gao, Y., Z. Li, M. Sun, H. Li, C. Guo, J. Cui, A. Li, F. Cao, Y. Xi, H. Lou, and G. Zhai. 2010. Preparation, characterization, pharmacokinetics, and tissue distribution of curcumin nanosuspension with TPGS as stabilizer. Drug Development & Industrial Pharmacy 36 (10):1225–34. doi:10.3109/03639041003695139
   PubMed Web of Science ®Google Scholar
• Gao, Y., C. Wang, M. Sun, X. Wang, A. Yu, A. Li, and G. Zhai. 2012. In vivo evaluation of curcumin loaded nanosuspensions by oral administration. Journal of Biomedical Nanotechnology 8 (4):659–68. doi:10.1166/jbn.2012.1425
   PubMed Web of Science ®Google Scholar
• Hu, X., X. Chen, L. Zhang, X. Lin, Y. Zhang, X. Tang, and Y. Wang. 2014. A combined bottom–up/top–down approach to prepare a sterile injectable nanosuspension. International Journal of Pharmaceutics 472 (1):130–39. doi:10.1016/j.ijpharm.2014.06.018
   PubMed Web of Science ®Google Scholar
• Hu, X., X. Lin, Y. Gu, Z. Liu, Y. Tang, Y. Zhang, X. Chen, Y. Wang, and X. Tang. 2014. Biocompatible riboflavin laurate long-acting injectable nanosuspensions allowing sterile filtration. Drug Delivery 21 (5):351–61. doi:10.3109/10717544.2013.850760
   PubMed Web of Science ®Google Scholar
• Kumar, A., A. Ahuja, J. Ali, and S. Baboota. 2010. Conundrum and therapeutic potential of curcumin in drug delivery. Critical Reviews™ in Therapeutic Drug Carrier Systems 27 (4):279–312. doi:10.1615/critrevtherdrugcarriersyst.v27.i4.10
   PubMed Web of Science ®Google Scholar
• Leng, D., H. Chen, G. Li, M. Guo, Z. Zhu, L. Xu, and Y. Wang. 2014. Development and comparison of intramuscularly long-acting paliperidone palmitate nanosuspensions with different particle size. International Journal of Pharmaceutics 472 (1):380–85. doi:10.1016/j.ijpharm.2014.05.052
   PubMed Web of Science ®Google Scholar
• Li, B., S. Konecke, L. A. Wegiel, L. S. Taylor, and K. J. Edgar. 2013. Both solubility and chemical stability of curcumin are enhanced by solid dispersion in cellulose derivative matrices. Carbohydrate Polymers 98 (1):1108–16. doi:10.1016/j.carbpol.2013.07.017
   PubMed Web of Science ®Google Scholar
• Li, X., H. Yuan, C. Zhang, W. Chen, W. Cheng, X. Chen, and X. Ye. 2016. Preparation and in‐vitro/in‐vivo evaluation of curcumin nanosuspension with solubility enhancement. Journal of Pharmacy & Pharmacology 68 (8):980–88. doi:10.1111/jphp.12575
   PubMed Web of Science ®Google Scholar
• Munjal, B., Y. B. Pawar, S. B. Patel, and A. K. Bansal. 2011. Comparative oral bioavailability advantage from curcumin formulations. Drug Delivery & Translational Research 1 (4):322–31. doi:10.1007/s13346-011-0033-3
   PubMed Web of Science ®Google Scholar
• Rachmawati, H, D. K. Budiputra, and R Mauludin. 2015. Curcumin nanoemulsion for transdermal application: Formulation and evaluation. Drug Development & Industrial Pharmacy 41 (4):560–66. doi:10.3109/03639045.2014.884127
   PubMed Web of Science ®Google Scholar
• Rundfeldt, C., H. Steckel, H. Scherliess, E. Wyska, and P. Wlaź. 2013. Inhalable highly concentrated itraconazole nanosuspension for the treatment of bronchopulmonary aspergillosis. European Journal of Pharmaceutics and Biopharmaceutics 83 (1):44–53. doi:10.1016/j.ejpb.2012.09.018
   PubMed Web of Science ®Google Scholar
• Seo, S.-W., H.-K. Han, M.-K. Chun, and H.-K. Choi. 2012. Preparation and pharmacokinetic evaluation of curcumin solid dispersion using Solutol® HS15 as a carrier. International Journal of Pharmaceutics 424 (1):18–25. doi:10.1016/j.ijpharm.2011.12.051
   PubMed Web of Science ®Google Scholar
• Shin, G. H., J. Li, H. C. Jin, J. T. Kim, and H. J. Park. 2016. Enhancement of curcumin solubility by phase change from crystalline to amorphous in Cur-TPGS nanosuspension. Journal of Food Science 81 (2):N494–501. doi:10.1111/1750-3841.13208
   PubMed Web of Science ®Google Scholar
• Wang, Y., C. Wang, Z. Jing, Y. Ding, and L. Lei. 2016. A cost-effective method to prepare curcumin nanosuspensions with enhanced oral bioavailability. Journal of Colloid & Interface Science 485:91–98. doi:10.1016/j.jcis.2016.09.003
   PubMed Web of Science ®Google Scholar
• Wei, X.-L., Y.-R. Han, L.-H. Quan, C.-Y. Liu, and Y.-H. Liao. 2013. Oily nanosuspension for long-acting intramuscular delivery of curcumin didecanoate prodrug: Preparation, characterization and in vivo evaluation. European Journal of Pharmaceutical Sciences 49 (2):286–93. doi:10.1016/j.ejps.2013.03.010
   PubMed Web of Science ®Google Scholar
• Yallapu, M. M., M. Jaggi, and S. C. Chauhan. 2012. Curcumin nanoformulations: A future nanomedicine for cancer. Drug Discovery Today 17 (1):71–80. doi:10.1016/j.drudis.2011.09.009
   PubMed Web of Science ®Google Scholar
• Zhongfa, L., M. Chiu, J. Wang, W. Chen, W. Yen, P. Fan-Havard, L. D. Yee, and K. K. Chan. 2012. Enhancement of curcumin oral absorption and pharmacokinetics of curcuminoids and curcumin metabolites in mice. Cancer Chemotherapy and Pharmacology 69 (3):679–89. doi:10.1007/s00280-011-1749-y
   PubMed Web of Science ®Google Scholar